Navigation Links
Doctors may be giving the wrong dosage of adrenaline in an emergency because of labelling
Date:12/31/2007

A new study by Cambridge University reveals that doctors treating life-threatening emergencies such as allergy attacks may give the wrong dosage of adrenaline (epinephrine) because of confusing labelling.

Adrenaline is stored in salt water in glass ampoules which are broken open when the drug is needed. The amount of adrenaline contained in the ampoule is usually expressed as both a dose (1 mg of the drug per 1 mL of salt water) and a ratio (1 part drug for every 1000 parts of salt water) on the label.

The ratio requires doing arithmetic to figure out how much drug to give. Therefore, doctors understand doses much better (and quicker) than ratios. Dr Daniel Wheeler at the University of Cambridge concluded from his research that having to do extra calculations to figure out how much adrenaline to give a person in an emergency might lead to the errors and delays which are common in administering the drug.

Dr Wheeler said: It is well documented that patients are commonly given the wrong dosage of adrenaline.

In order to determine whether the labelling was indeed the cause of the high number of dosing errors, the researchers set up mock scenarios. They programmed a medical mannequin to look like it was having a life-threatening allergic reaction. They then gave the doctors ampoules of adrenaline and told them to treat the emergency.

One half of the doctors were randomly assigned to ampoules with labels that had the adrenaline dose. The other half were randomly assigned to ampoules with labels that had the amount of adrenaline expressed as a ratio. The researchers then measured the amount of drug the doctors gave and how long it took them to give it.

All but 2 doctors out of 14 whose ampoules with labels that expressed the amount of adrenaline as a ratio overdosed their patients. Because they had to figure out how much drug to give, the doctors using ampoules labeled with a ratio also took about 1.5 minutes longer to give it.

The findings might be different if the doctors had to treat a real person. In reality, the labels have doses and ratios, not one or the other, said Dr Wheeler. However, this does give us insight into the problem and a fairly easy solution expressing drug concentrations exclusively as doses we believe would improve patient safety.


'/>"/>
Contact: Dr Daniel Wheeler
dww21@cam.ac.uk
44-019-542-11971
University of Cambridge
Source:Eurekalert

Related biology news :

1. Doctors learn to control their own brains pain responses to better treat patients
2. Drug dosages often incorrect for obese patients
3. Triage study challenges notions of emergency medical response to disaster
4. Human embryonic stem cells remain embryonic because of epigenetic factors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... LONDON , April 4, 2017 KEY ... is anticipated to expand at a CAGR of 25.76% ... neurodegenerative diseases is the primary factor for the growth ... full report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The ... of product, technology, application, and geography. The stem cell ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/30/2017)... 30, 2017 The research team of The ... (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery ... of speed and accuracy for use in identification, crime investigation, immigration ... ... A research team ...
Breaking Biology News(10 mins):
(Date:10/10/2017)... , ... October 10, 2017 ... ... cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing ... HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and CEO ... Diego Rotary Club. The event entitled “Stem Cells and Their Regenerative ... attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: Peter B. ...
(Date:10/10/2017)... , Oct. 10, 2017 SomaGenics announced ... the NIH to develop RealSeq®-SC (Single Cell), expected to ... profiling small RNAs (including microRNAs) from single cells using ... highlights the need to accelerate development of approaches to ... "New techniques for measuring levels of ...
(Date:10/10/2017)... ... October 10, 2017 , ... The Pittcon Program Committee ... honoring scientists who have made outstanding contributions to analytical chemistry and applied ... the world’s leading conference and exposition for laboratory science, which will be held ...
Breaking Biology Technology: